MIRA Pharmaceuticals, Inc. (MIRA)

USD 1.05

(-1.87%)

Net Income Summary of MIRA Pharmaceuticals, Inc.

MIRA Pharmaceuticals, Inc.'s latest annual net income in 2023 was -11.98 Million USD , down -69.77% from previous year.
MIRA Pharmaceuticals, Inc.'s latest quarterly net income in 2024 Q2 was -1.69 Million USD , up 1.54% from previous quarter.
MIRA Pharmaceuticals, Inc. reported an annual net income of -7.05 Million USD in 2022, down -224.29% from previous year.
MIRA Pharmaceuticals, Inc. reported an annual net income of -2.17 Million USD in 2021, down -3101.12% from previous year.
MIRA Pharmaceuticals, Inc. reported a quarterly net income of -1.69 Million USD for 2024 Q2, up 1.54% from previous quarter.
MIRA Pharmaceuticals, Inc. reported a quarterly net income of -1.34 Million USD for 2023 Q1, up 0.63% from previous quarter.

Annual Net Income Chart of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Historical Annual Net Income of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Year	Net Income	Net Income Growth
2023	-11.98 Million USD	-69.77%
2022	-7.05 Million USD	-224.29%
2021	-2.17 Million USD	-3101.12%
2020	-67.99 Thousand USD	0.0%

Year	Net Income	Net Income Growth
2024 Q1	-1.71 Million USD	70.32%
2024 Q2	-1.69 Million USD	1.54%
2023 Q1	-1.34 Million USD	0.63%
2023 Q3	-3.58 Million USD	-183.37%
2023 FY	-11.98 Million USD	-69.77%
2023 Q4	-5.78 Million USD	-61.31%
2023 Q2	-1.26 Million USD	5.59%
2022 Q3	-1.81 Million USD	25.27%
2022 FY	-7.05 Million USD	-224.29%
2022 Q1	-1.47 Million USD	0.0%
2022 Q4	-1.34 Million USD	25.47%
2022 Q2	-2.42 Million USD	-64.26%
2021 Q1	-56.97 Thousand USD	0.0%
2021 FY	-2.17 Million USD	-3101.12%
2020 FY	-67.99 Thousand USD	0.0%

Peer Net Income Comparison of MIRA Pharmaceuticals, Inc.

Name	Net Income	Net Income Difference
Amgen Inc.	6.71 Billion USD	100.178%
AstraZeneca PLC	5.95 Billion USD	100.201%
Biogen Inc.	1.16 Billion USD	101.032%
Gilead Sciences, Inc.	5.66 Billion USD	100.212%
Scilex Holding Company	-114.33 Million USD	89.52%
Scilex Holding Company	-114.33 Million USD	89.52%